187 related articles for article (PubMed ID: 11943934)
1. The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma model.
van der Neut Kolfschoten M; Dirven RJ; Tans G; Rosing J; Vos HL; Bertina RM
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):207-15. PubMed ID: 11943934
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
3. Does activated protein C-resistant factor V contribute to thrombin generation in hemophilic plasma?
Bos MH; Meijerman DW; van der Zwaan C; Mertens K
J Thromb Haemost; 2005 Mar; 3(3):522-30. PubMed ID: 15748243
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
Steen M; Norstrøm EA; Tholander AL; Bolton-Maggs PH; Mumford A; McVey JH; Tuddenham EG; Dahlbäck B
Blood; 2004 May; 103(9):3381-7. PubMed ID: 14695241
[TBL] [Abstract][Full Text] [Related]
5. Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden.
Nogami K; Shinozawa K; Ogiwara K; Matsumoto T; Amano K; Fukutake K; Shima M
Blood; 2014 Apr; 123(15):2420-8. PubMed ID: 24523236
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.
Cai H; Hua B; Fan L; Wang Q; Wang S; Zhao Y
Thromb Res; 2010 Jun; 125(6):545-8. PubMed ID: 20304467
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilia as a multigenic disease.
Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
[TBL] [Abstract][Full Text] [Related]
9. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
Dahlbäck B
Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
Aparicio C; Dahlbäck B
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
Norstrøm E; Thorelli E; Dahlbäck B
Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
[TBL] [Abstract][Full Text] [Related]
12. The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505.
Dirven RJ; Vos HL; Bertina RM
Thromb Res; 2010 May; 125(5):444-50. PubMed ID: 20051284
[TBL] [Abstract][Full Text] [Related]
13. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
Bossone A; Cappucci F; D'Andrea G; Brancaccio V; Cibelli G; Iannaccone L; Grandone E; Margaglione M
Haematologica; 2003 Mar; 88(3):286-9. PubMed ID: 12651267
[TBL] [Abstract][Full Text] [Related]
14. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden: a disorder of factor V anticoagulant function.
Castoldi E; Rosing J
Curr Opin Hematol; 2004 May; 11(3):176-81. PubMed ID: 15257017
[TBL] [Abstract][Full Text] [Related]
16. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
Ivey LM; Thom JY; Ivey JG; Baker RI
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
Silveira JR; Kalafatis M; Tracy PB
Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
[TBL] [Abstract][Full Text] [Related]
19. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
